S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(-0.05%) $0.926
USD/NOK
(-0.06%) $10.83
USD/GBP
(-0.10%) $0.791
USD/RUB
(-0.09%) $92.50

Realtime updates for Bukwang Pharmaceutical [003000.KS]

Exchange: KSC Sector: Healthcare Industry: Drug Manufacturersā€”Specialty & Generic
Last Updated29 Mar 2024 @ 02:30

-6.06% KRW 6 660.00

Live Chart Being Loaded With Signals

Commentary (29 Mar 2024 @ 02:30):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Bukwang Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. It manufactures oral solid dosage forms, injections, oral solutions, external-use solutions, and ointments...

Stats
Today's Volume 1.35M
Average Volume 987 396
Market Cap 455.91B
EPS KRW0 ( 2024-02-08 )
Next earnings date ( KRW0 ) 2024-05-13
Last Dividend KRW0 ( N/A )
Next Dividend KRW0 ( N/A )
P/E 0
ATR14 KRW10.27 (0.15%)

Volume Correlation

Long: 0.16 (neutral)
Short: -0.91 (very strong negative)
Signal:(36.23) Neutral

Bukwang Pharmaceutical Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Bukwang Pharmaceutical Correlation - Currency/Commodity

The country flag 0.24
( neutral )
The country flag 0.39
( neutral )
The country flag -0.33
( neutral )
The country flag 0.07
( neutral )
The country flag 0.53
( weak )
The country flag 0.00
( neutral )

Bukwang Pharmaceutical Financials

Annual 2023
Revenue: KRW125.93B
Gross Profit: KRW50.05B (39.74 %)
EPS: KRW-457.67
Q4 2023
Revenue: KRW25.02B
Gross Profit: KRW18.49B (73.92 %)
EPS: KRW-157.72
Q3 2023
Revenue: KRW20.25B
Gross Profit: KRW6.22B (30.70 %)
EPS: KRW-235.35
Q2 2023
Revenue: KRW43.42B
Gross Profit: KRW17.31B (39.87 %)
EPS: KRW7.00

Financial Reports:

No articles found.

Bukwang Pharmaceutical

Bukwang Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. It manufactures oral solid dosage forms, injections, oral solutions, external-use solutions, and ointments. The company offers products in various therapeutic areas, including liver disease treatments, such as Levovir and Legalon; diabetic complication products comprising Dexid and Thioctacid; CNS disorder drugs consisting of Lonasen, Ixel, and Orfil; and respiratory disease treatments, which comprise Azeptin and Asima. It also provides OTC products; toothpastes, and hair and skin care goods; and nutritional supplements. In addition, the company offers products for antihistamines, hepatitis and gastrointestinal, sedative and antidote, anti-cancer, thyroid and osteoporosis, diabetes, obstetrics, urinogenital, cardiovascular, dermatology, obesity, pain relief, and muscle relaxant. Further, it provides products for bruises, skin and mucous membrane, rhinitis, cold symptoms, cough, phlegm and asthma, rheumatoid arthritis, osteoarthritis, pain caused by cold and fever, dysmenorrhea, NSAIDs, inflammation, joint inflammation, tinea pedis, infected wounds, dermatitis, antivirals-herpes, eczema, diarrhea, dyspepsia, sense of distension, anti-histamine, anti-ulcer, constipation, anemia, pregnant multivitamins, candidiasis, athlete's foot, onychomycosis, stomatitis, pimple, acne, physical fatigue, neuralgia, myalgia, and arthralgia. Additionally, the company offers medicines for period of lactation, rickets, night blindness, varicose vein, and sputum; and quasi drugs and medical devices, as well as health functional food. It also develops anti-diabetes compound with Melior Pharmaceuticals; and anti-cancer drugs with LSK BioPartners, as well as cell therapies using adult stem cells, as well as holds a license for a novel candidate to treat movement disorder in Parkinson's disease patients. The company was founded in 1960 and is based in Seoul, South Korea.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators